These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 28731917

  • 1. The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress.
    Olcay L, Serteser M, Kolay M, Balci HF, Yildirim ÜM, Tekgündüz SA, Hazirolan T, Terzi YK.
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):425-439. PubMed ID: 28731917
    [Abstract] [Full Text] [Related]

  • 2. Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications.
    Belotti A, Duca L, Borin L, Realini S, Renso R, Parma M, Pioltelli P, Pogliani E, Cappellini MD.
    Leuk Res; 2015 Jan; 39(1):88-91. PubMed ID: 25435028
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).
    Hilken A, Langebrake C, Wolschke C, Kersten JF, Rohde H, Nielsen P, Kröger N.
    Ann Hematol; 2017 Aug; 96(8):1379-1388. PubMed ID: 28585071
    [Abstract] [Full Text] [Related]

  • 5. Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters.
    Halonen P, Mattila J, Suominen P, Ruuska T, Salo MK, Mäkipernaa A.
    Pediatrics; 2003 Jan; 111(1):91-6. PubMed ID: 12509560
    [Abstract] [Full Text] [Related]

  • 6. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD.
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [Abstract] [Full Text] [Related]

  • 7. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload.
    McNamara L, MacPhail AP, Mandishona E, Bloom P, Paterson AC, Rouault TA, Gordeuk VR.
    J Gastroenterol Hepatol; 1999 Feb; 14(2):126-32. PubMed ID: 10029292
    [Abstract] [Full Text] [Related]

  • 8. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB, Cappellini MD, Kattamis A, Viprakasit V, Musallam KM, Zhu Z, Taher AT.
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [Abstract] [Full Text] [Related]

  • 9. Non-transferrin-bound iron induced by myeloablative chemotherapy.
    Bradley SJ, Gosriwitana I, Srichairatanakool S, Hider RC, Porter JB.
    Br J Haematol; 1997 Nov; 99(2):337-43. PubMed ID: 9375751
    [Abstract] [Full Text] [Related]

  • 10. Nontransferrin-bound iron in transfused patients with sickle cell disease.
    Inati A, Musallam KM, Cappellini MD, Duca L, Taher AT.
    Int J Lab Hematol; 2011 Apr; 33(2):133-7. PubMed ID: 21382180
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
    Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC.
    Anal Biochem; 1999 Sep 10; 273(2):212-20. PubMed ID: 10469492
    [Abstract] [Full Text] [Related]

  • 16. Iron metabolism in kidney allograft recipients: still a mystery?
    Malyszko J, Głowińska I, Malyszko JS, Levin-Iaina N, Koc-Zorawska E, Mysliwiec M.
    Transplant Proc; 2011 Oct 10; 43(8):2973-5. PubMed ID: 21996204
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oxidative status and malondialdehyde in beta-thalassaemia patients.
    Cighetti G, Duca L, Bortone L, Sala S, Nava I, Fiorelli G, Cappellini MD.
    Eur J Clin Invest; 2002 Mar 10; 32 Suppl 1():55-60. PubMed ID: 11886433
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
    Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, Cappellini MD.
    Br J Haematol; 2009 Sep 10; 146(5):569-72. PubMed ID: 19604239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.